EUVIMEDEUVIMED entdecken
Metaanalyse

Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-Analysis of Randomized Clinical Trials

Wulamiding Kaisaier, Yili Chen, Yugang Dong, Jiangui He, Tong Liu, Chen Liu, Wengen Zhu

Thrombosis and Haemostasis · 15.07.2026

DOI: 10.1055/a-2906-7109 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Thrombosis and Haemostasis, erschienen am 15.07.2026. Verfasst von Wulamiding Kaisaier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Natural Science Foundation, Sun Yat-sen University Clinical Research 5010 Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current guidelines recommend indefinite oral anticoagulant (OAC) therapy for atrial fibrillation (AF) patients with stroke risk factors, regardless of catheter ablation (CA) outcomes. However, these recommendations are largely based on nonrandomized evidence, and the long-term anticoagulation strategy for patients after successful CA for AF remains uncertain. To evaluate the efficacy and safety of discontinuing OAC versus continuing OAC in AF with successful CA. We searched PubMed, Embase, and major conference proceedings from inception to November 2025 to identify eligible randomized controlled trials (RCTs). Pooled effect estimates were calculated as risk differences (RDs) with 95% confidence intervals (CIs). A total of 2,324 patients were included across three RCTs, with the mean age ranging from 63 to 67 years, 71.4% were men, and the average CHA2DS2-VASc score was approximately 2. Among patients with successful CA, OAC discontinuation was not associated with a significant increase in the risks of stroke, ischemic stroke, stroke or systemic embolism, transient ischemic attack, and all-cause death. In contrast, continued OAC was associated with significantly higher risks of major bleeding (RD: 1.0%, 95% CI: 0.2–1.7), intracranial bleeding (RD: 0.6%, 95 CI: 0.0-1.1), minor bleeding (RD: 2.2%, 95% CI: 0.2–4.1), and clinically relevant nonmajor bleeding (RD: 2.5%, 95% CI: 1.2–3.9). No statistically significant difference was observed in gastrointestinal bleeding between groups. In patients with AF and moderate baseline stroke risk after successful CA, discontinuation of OAC was associated with a lower risk of bleeding complications and was not associated with a statistically significant increase in thromboembolic events. These findings are primarily applicable to patients with moderate stroke risk and should not be extrapolated to higher-risk populations.

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.

Förderung

  • National Natural Science Foundation of China
  • Guangdong Natural Science Foundation
  • Sun Yat-sen University Clinical Research 5010 Program

Zitieren

APA

Kaisaier, W., Chen, Y., Dong, Y., He, J., Liu, T., Liu, C., & Zhu, W. (2026). Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-Analysis of Randomized Clinical Trials. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2906-7109

Vancouver

Kaisaier W, Chen Y, Dong Y, He J, Liu T, Liu C, et al. Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-Analysis of Randomized Clinical Trials. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2906-7109

BibTeX
@article{Kaisaier2026,
  author = {Kaisaier, Wulamiding and Chen, Yili and Dong, Yugang and He, Jiangui and Liu, Tong and Liu, Chen and Zhu, Wengen},
  title = {Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-Analysis of Randomized Clinical Trials},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2906-7109}
}
Kostenlos starten →